Investment Research
Is Matthews China Fund (MCHFX) a Strong Mutual Fund Pick Right Now?
Having trouble finding a China - Equity fund? Matthews China Fund (MCHFX) is a potential starting point. MCHFX possesses a...
Edited Transcript of SCST.ST earnings conference call or presentation 7-Feb-20 7:30am GMT
Stockholm Feb 11, 2020 (Thomson StreetEvents) -- Edited Transcript of Scandi Standard AB (publ) earnings conference call or presentation Friday,...
Edited Transcript of ENTA earnings conference call or presentation 6-Feb-20 9:30pm GMT
WATERTOWN Feb 10, 2020 (Thomson StreetEvents) -- Edited Transcript of Enanta Pharmaceuticals Inc earnings conference call or presentation Thursday, February...
Edited Transcript of CBOE earnings conference call or presentation 7-Feb-20 1:30pm GMT
CHICAGO Feb 11, 2020 (Thomson StreetEvents) -- Edited Transcript of Cboe Global Markets Inc earnings conference call or presentation Friday,...
Form DEFA14A TAUBMAN CENTERS INC
UNITED STATESSECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) ofthe Securities Exchange...
Semiconductor demand set to be curtailed: Citi Research, Economy News & Top Stories
Although the Asian semiconductor industry has shown signs of a strong recovery for much of the past quarter, this could...
Credit Suisse Group Increases Paycom Software (NYSE:PAYC) Price Target to $290.00
Paycom Software (NYSE:PAYC) had its price target increased by Credit Suisse Group from $235.00 to $290.00 in a report issued...
3 Fidelity Mutual Funds to Grab Now – February 10, 2020
Fidelity Investments is considered one of the leaders in the financial services industry with presence in eight countries across North...
Biogen (NASDAQ:BIIB) Earns “Sell” Rating from Robert W. Baird
Robert W. Baird reaffirmed their sell rating on shares of Biogen (NASDAQ:BIIB) in a research note released on Thursday, January...
Intercept Pharmaceuticals (NASDAQ:ICPT) Lowered to “Sell” at BidaskClub
BidaskClub downgraded shares of Intercept Pharmaceuticals (NASDAQ:ICPT) from a hold rating to a sell rating in a research report released...
